Real-world bleeding rates on emicizumab: the value of using nationwide digital treatment diary data in clinical research

Background: People with hemophilia in the Netherlands log bleeds and infusions through a digital treatment diary. With the current innovations in hemophilia treatments, the use of patient-reported bleeding data will become increasingly important. Objective: To assess real-world bleeding rates on emi...

Cijeli opis

Bibliografski detalji

Glavni autori:	Martijn R. Brands, Elisabeth M. Taal, Martijn Oude Voshaar, Mariëtte H.E. Driessens, Caroline M.E. van Veen, Marieke J.H.A. Kruip, Paul L. den Exter, Britta A.P. Laros-van Gorkom, Marjet A. Stein-Wit, Kathelijn Fischer, Stephan Meijer, Karina Meijer, Marlène Beijlevelt, Karin Fijnvandraat, Samantha C. Gouw
Format:	Artigo
Jezik:	Inglês
Izdano:	Elsevier 2025-02-01
Serija:	Research and Practice in Thrombosis and Haemostasis
Teme:	emicizumab hemophilia A patient-generated health data registries telemedicine
Online pristup:	http://www.sciencedirect.com/science/article/pii/S247503792500041X
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!